End-of-day quote
Taipei Exchange
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
22.65
TWD
|
-0.44%
|
|
+0.44%
|
-9.40%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
762.5
|
872.5
|
1,670
|
1,779
|
2,077
|
2,123
|
Enterprise Value (EV)
1 |
317.5
|
959
|
1,539
|
1,931
|
2,378
|
2,818
|
P/E ratio
|
46
x
|
34
x
|
11.5
x
|
15.9
x
|
12.2
x
|
-313
x
|
Yield
|
0.96%
|
1.68%
|
5.7%
|
5.17%
|
4.91%
|
-
|
Capitalization / Revenue
|
0.25
x
|
0.28
x
|
0.45
x
|
0.45
x
|
0.48
x
|
0.56
x
|
EV / Revenue
|
0.1
x
|
0.31
x
|
0.42
x
|
0.49
x
|
0.55
x
|
0.74
x
|
EV / EBITDA
|
5.3
x
|
15.5
x
|
7.43
x
|
9.58
x
|
7.18
x
|
34.4
x
|
EV / FCF
|
-6.27
x
|
5.21
x
|
7.19
x
|
-38.2
x
|
13
x
|
55.3
x
|
FCF Yield
|
-16%
|
19.2%
|
13.9%
|
-2.62%
|
7.69%
|
1.81%
|
Price to Book
|
0.68
x
|
0.78
x
|
1.24
x
|
1.23
x
|
1.34
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
73,317
|
73,317
|
79,317
|
84,323
|
84,929
|
84,929
|
Reference price
2 |
10.40
|
11.90
|
21.05
|
21.10
|
24.45
|
25.00
|
Announcement Date
|
19-03-19
|
20-03-30
|
21-03-19
|
22-03-14
|
23-03-16
|
24-03-12
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,097
|
3,094
|
3,679
|
3,948
|
4,345
|
3,809
|
EBITDA
1 |
59.89
|
61.75
|
207.1
|
201.7
|
331.2
|
81.81
|
EBIT
1 |
-7.591
|
0.161
|
147.8
|
134.1
|
258.5
|
4.473
|
Operating Margin
|
-0.25%
|
0.01%
|
4.02%
|
3.4%
|
5.95%
|
0.12%
|
Earnings before Tax (EBT)
1 |
21.12
|
37.07
|
180.4
|
159.5
|
273.3
|
15.6
|
Net income
1 |
16.59
|
25.73
|
135.5
|
111.4
|
170.3
|
-6.665
|
Net margin
|
0.54%
|
0.83%
|
3.68%
|
2.82%
|
3.92%
|
-0.17%
|
EPS
2 |
0.2262
|
0.3500
|
1.830
|
1.325
|
1.998
|
-0.0800
|
Free Cash Flow
1 |
-50.64
|
184.1
|
214.2
|
-50.61
|
182.8
|
50.92
|
FCF margin
|
-1.64%
|
5.95%
|
5.82%
|
-1.28%
|
4.21%
|
1.34%
|
FCF Conversion (EBITDA)
|
-
|
298.15%
|
103.44%
|
-
|
55.2%
|
62.24%
|
FCF Conversion (Net income)
|
-
|
715.64%
|
158.15%
|
-
|
107.39%
|
-
|
Dividend per Share
2 |
0.1000
|
0.2000
|
1.200
|
1.090
|
1.200
|
-
|
Announcement Date
|
19-03-19
|
20-03-30
|
21-03-19
|
22-03-14
|
23-03-16
|
24-03-12
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
86.6
|
-
|
152
|
302
|
695
|
Net Cash position
1 |
445
|
-
|
130
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.402
x
|
-
|
0.7549
x
|
0.9104
x
|
8.491
x
|
Free Cash Flow
1 |
-50.6
|
184
|
214
|
-50.6
|
183
|
50.9
|
ROE (net income / shareholders' equity)
|
0.95%
|
1.8%
|
10.3%
|
7.42%
|
11.7%
|
0.03%
|
ROA (Net income/ Total Assets)
|
-0.2%
|
0%
|
2.88%
|
2.36%
|
4.17%
|
0.07%
|
Assets
1 |
-8,235
|
695,324
|
4,706
|
4,724
|
4,084
|
-9,645
|
Book Value Per Share
2 |
15.30
|
15.30
|
16.90
|
17.10
|
18.30
|
17.00
|
Cash Flow per Share
2 |
5.580
|
6.160
|
6.770
|
7.220
|
6.010
|
5.690
|
Capex
1 |
46.5
|
41.5
|
77.9
|
344
|
134
|
105
|
Capex / Sales
|
1.5%
|
1.34%
|
2.12%
|
8.72%
|
3.09%
|
2.75%
|
Announcement Date
|
19-03-19
|
20-03-30
|
21-03-19
|
22-03-14
|
23-03-16
|
24-03-12
|
|
1st Jan change
|
Capi.
|
---|
| -9.40% | 59.26M | | +73.46% | 12.41B | | -15.61% | 8.23B | | +3.88% | 6.46B | | +14.69% | 5.5B | | -5.53% | 5.33B | | +42.58% | 5.1B | | -32.61% | 2.54B | | +10.80% | 1.99B | | -0.74% | 1.99B |
Medical Equipment
|